Heart Rate Variability and Postoperative Nausea Vomiting
NCT ID: NCT04514211
Last Updated: 2022-02-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2020-10-17
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevention of Post-Operative Nausea and Vomiting With Propofol Infusion
NCT05759481
The Effects of Anesthetic Techniques and Palonosetron Administration on the Incidence of PONV
NCT02809378
Propofol Versus Dexmedetomidine on the Incidence of Postoperative Nausea and Vomiting
NCT05875077
Postoperative Nausea and Vomiting: to Estimate the Incidence and Risk Factors in a Tertiary Teaching Hospital
NCT02689128
The Effect of Glycyrrhizin on the Occurrence of Postoperative Nausea and Vomiting
NCT04742660
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Several studies have been reported that preoperative heart rate variability predicted the occurence of postoperative nausea and vomiting. However, whether the difference in heart rate variability after anesthesia is related to the difference in postoperative nausea and vomiting has not been studied. Therefore, this study aims to observe whether propofol and sevoflurane have differences during recovery period after anesthesia in heart rate variabiliy. In addition, we want to examine that these differences during recovery period in heart rate variability can predict the occurrence of nausea and vomiting within 24 hours after surgery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Propofol
General anesthesia using propofol infusion
Propofol
General anesthesia using propofol infusion
Sevoflurane
General anesthesia using sevoflurane
Sevoflurane
General anesthesia using sevoflurane
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Propofol
General anesthesia using propofol infusion
Sevoflurane
General anesthesia using sevoflurane
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Uncooperative with the measuring heart rate variability
* Diabetes
* Hypertension on medication
* Patients taking psychiatric drugs
* Thyroid disease
20 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ajou University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
In-kyong Yi
assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
In Kyong Yi, MD
Role: PRINCIPAL_INVESTIGATOR
Ajou University School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ajou university school of medicine
Suwon, Gyeonggi-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AJIRB-MED-OBS-20-293
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.